Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
NCT ID: NCT00528905
Last Updated: 2008-11-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
400 participants
INTERVENTIONAL
2007-08-31
2008-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Placebo
AZD3480
oral capsule
2
AZD3480 oral
AZD3480
oral capsule
3
AZD3480 oral dose
AZD3480
oral capsule
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
AZD3480
oral capsule
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Outpatient at the time of screening and randomization
* Stable housing defined as having a place to live in the community (ie, not in a hospital or nursing home)
* Active cigarette smoking (10 or more cigarettes per day
Exclusion Criteria
* Known or suspected drug or alcohol abuse within the 6 months or urine toxicology test positive for illegal or non-prescribed substances
* Impaired vision and/or hearing making cognitive testing difficult
18 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Larry Rodichok, MD
Role: STUDY_DIRECTOR
AstraZeneca
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Little Rock, Arkansas, United States
Research Site
Anaheim, California, United States
Research Site
Cerritos, California, United States
Research Site
Costa Mesa, California, United States
Research Site
Escondido, California, United States
Research Site
Garden Grove, California, United States
Research Site
Long Beach, California, United States
Research Site
Los Angeles, California, United States
Research Site
Oceanside, California, United States
Research Site
Pasadena, California, United States
Research Site
Pico Rivera, California, United States
Research Site
San Diego, California, United States
Research Site
Santa Ana, California, United States
Research Site
New Britain, Connecticut, United States
Research Site
New Haven, Connecticut, United States
Research Site
Washington D.C., District of Columbia, United States
Research Site
Boca Raton, Florida, United States
Research Site
Coral Gables, Florida, United States
Research Site
North Miami, Florida, United States
Research Site
Orlando, Florida, United States
Research Site
Tampa, Florida, United States
Research Site
Atlanta, Georgia, United States
Research Site
Augusta, Georgia, United States
Research Site
Marietta, Georgia, United States
Research Site
Chicago, Illinois, United States
Research Site
Joliet, Illinois, United States
Research Site
Schaumburg, Illinois, United States
Research Site
Indianapolis, Indiana, United States
Research Site
New Orleans, Louisiana, United States
Research Site
Glen Burnie, Maryland, United States
Research Site
Haverhill, Massachusetts, United States
Research Site
Pittsfield, Massachusetts, United States
Research Site
Minneapolis, Minnesota, United States
Research Site
St Louis, Missouri, United States
Research Site
Las Vegas, Nevada, United States
Research Site
Nashua, New Hampshire, United States
Research Site
Cherry Hill, New Jersey, United States
Research Site
Clementon, New Jersey, United States
Research Site
East Orange, New Jersey, United States
Research Site
Newark, New Jersey, United States
Research Site
Paramus, New Jersey, United States
Research Site
Brooklyn, New York, United States
Research Site
Cedarhurst, New York, United States
Research Site
Elmsford, New York, United States
Research Site
Glen Oaks, New York, United States
Research Site
Jamaica, New York, United States
Research Site
New York, New York, United States
Research Site
Rochester, New York, United States
Research Site
Staten Island, New York, United States
Research Site
Cincinnati, Ohio, United States
Research Site
Columbus, Ohio, United States
Research Site
Kettering, Ohio, United States
Research Site
Oklahoma City, Oklahoma, United States
Research Site
Allentown, Pennsylvania, United States
Research Site
DuBois, Pennsylvania, United States
Research Site
Norristown, Pennsylvania, United States
Research Site
Philadelphia, Pennsylvania, United States
Research Site
Charleston, South Carolina, United States
Research Site
Memphis, Tennessee, United States
Research Site
Austin, Texas, United States
Research Site
DeSoto, Texas, United States
Research Site
Houston, Texas, United States
Research Site
Irving, Texas, United States
Research Site
San Antonio, Texas, United States
Research Site
Richmond, Virginia, United States
Research Site
Spokane, Washington, United States
Research Site
Calgary, Alberta, Canada
Research Site
Red Deer, Alberta, Canada
Research Site
Penticton, British Columbia, Canada
Research Site
Victoria, British Columbia, Canada
Research Site
Winnipeg, Manitoba, Canada
Research Site
Halifax, Nova Scotia, Canada
Research Site
Sydney, Nova Scotia, Canada
Research Site
Burlington, Ontario, Canada
Research Site
Greater Sudbury, Ontario, Canada
Research Site
Mississauga, Ontario, Canada
Research Site
Orléans, Ontario, Canada
Research Site
Toronto, Ontario, Canada
Research Site
Windsor, Ontario, Canada
Research Site
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
D3690C00011
Identifier Type: -
Identifier Source: org_study_id